Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rocket Doctor AI ( (TSE:AIDR) ) has shared an announcement.
Rocket Doctor AI Inc. has granted a total of 75,000 stock options, exercisable at $0.74 per share for three years, and 212,148 restricted share units, also with a three-year term, to its consultants under existing share compensation plans, with all awards vesting over one year. The equity-based incentives are aimed at aligning consultant interests with the company’s long-term growth in AI-driven healthcare, supporting Rocket Doctor AI’s efforts to scale its physician-focused decision support tools and virtual care platforms in key North American markets and reinforcing its positioning as a technology provider targeting efficiency and access in underserved healthcare segments.
The most recent analyst rating on (TSE:AIDR) stock is a Hold with a C$0.73 price target. To see the full list of analyst forecasts on Rocket Doctor AI stock, see the TSE:AIDR Stock Forecast page.
Spark’s Take on TSE:AIDR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDR is a Neutral.
The score is primarily held down by weak financial performance—minimal revenue scale, large operating losses, and sharply worsening cash burn—implying high execution and funding risk. Technicals are also soft (negative MACD and price below short/intermediate moving averages). Offsetting factors include a string of positive corporate developments (U.S. insurer access expansion, funding/grants, partnerships, and an announced acquisition), but valuation support is limited given negative earnings and no dividend yield provided.
To see Spark’s full report on TSE:AIDR stock, click here.
More about Rocket Doctor AI
Rocket Doctor AI Inc. operates in the digital health and AI-powered healthcare technology sector, offering physician-built decision support systems and virtual care platforms designed to make high-quality healthcare accessible across the patient journey. Its core technology includes the Global Library of Medicine, a clinically validated AI decision support system developed with input from hundreds of physicians worldwide, and Rocket Doctor Inc.’s AI-enabled digital health marketplace, which has supported more than 300 physicians in delivering over 700,000 patient visits through virtual and hybrid practices. The company focuses on improving clinical efficiency, reducing administrative burdens, and expanding access to care, particularly for underserved, rural, and remote communities in Canada and Medicaid and Medicare patients in the United States.
Average Trading Volume: 220,941
Technical Sentiment Signal: Buy
Current Market Cap: C$62.88M
Learn more about AIDR stock on TipRanks’ Stock Analysis page.